... chlorhexidine silver sulfadiazine; ICER, incremental cost effectiveness ratio; ICU, intensive care unit; int/ext, internally and externally coated; QALY, quality-adjusted life year; MR, minocycline and ... catheters; CH/SSD, chlorhexidine silver sulfadiazine; CR-BSI, catheter related bloodstream infection; ICU, intensive care unit; int/ext, internally and externally coated; MR, minocycline and ... uncertainty indicate that minocycline and rifampicin catheters generate the greatest health benefits (1.6 quality-adjusted life years) and opportunity cost savings (AUD $130,289 per 1,000 catheters...